Christine Fox

Christine (Chris) Fox was appointed Executive Vice President, U.S. Commercial for Teva Pharmaceuticals on November 20, 2023, with responsibility leading all commercial activities for Teva in the U.S., encompassing innovative medicines, biosimilars, and generics supporting billions of dollars in critical medicines for patients across a number of disease indications.  Chris’ role expanded in January 2025, to include leadership of the company’s global innovative medicines franchise to leverage her industry knowledge and experience to strengthen Teva’s commercial and marketing capabilities across its innovative medicines portfolio.

As a leader, Chris is dedicated to translating strategy into actionable execution that delivers results.  She cultivates inclusive, performance-driven cultures that utilize talents of individuals and teams to drive impactful business transformation.

Chris brings more than 30 years of healthcare industry experience with leadership roles in sales, marketing, and commercial operations, and is responsible for teams ranging from 2,500+ associates to small, nimble consulting teams. She has a deep understanding of issues affecting the pharmaceutical and biotech sectors, as well as expertise across a range of therapy areas.

Prior to Teva, Chris served as President at Novartis Gene Therapies since December 2021. Previously, Chris was vice president and general manager for the Bone, Cardiometabolic and Nephrology business for Amgen. She also served as the general manager of the company’s United Kingdom and Ireland affiliate. Earlier in her career, she also held leadership positions at Merck, Takeda, and several startups.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.